Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana M Tari

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Breast Cancer Research : BCR|May 14, 2008
TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cellsAnn-Marie Simeone, Vanity McMurtry, René Nieves-Alicea, et al.
International Journal of Oncology|October 4, 2007
Liposome-incorporated Grb2 antisense oligodeoxynucleotide increases the survival of mice bearing bcr-abl-positive leukemia xenograftsAna M Tari, Yolanda Gutiérrez-Puente, Giuseppe Monaco, et al.
Leukemia & Lymphoma|January 24, 2004
Cellular pharmacology of P-ethoxy antisense oligonucleotides targeted to Bcl-2 in a follicular lymphoma cell lineYolanda Gutiérrez-Puente, Ana M Tari, Richard J Ford, et al.
Molecular Cancer Therapeutics|November 4, 2010
Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹⁰ p27 phosphorylation in epidermal growth factor receptor-expressing breast cancerDongwei Zhang, Ana M Tari, Ugur Akar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastomaHiroshi Aoki, Tomohisa Yokoyama, Keishi Fujiwara, et al.
The Lancet. Oncology|June 2, 2009
Imaging bone metastases in breast cancer: techniques and recommendations for diagnosisColleen M Costelloe, Eric M Rohren, John E Madewell, et al.
Cancer Research|November 17, 2007
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinomaJyotsnabaran Halder, Yvonne G Lin, William M Merritt, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Breast Cancer Research : BCR|May 14, 2008
TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cellsAnn-Marie Simeone, Vanity McMurtry, René Nieves-Alicea, et al.
International Journal of Oncology|October 4, 2007
Liposome-incorporated Grb2 antisense oligodeoxynucleotide increases the survival of mice bearing bcr-abl-positive leukemia xenograftsAna M Tari, Yolanda Gutiérrez-Puente, Giuseppe Monaco, et al.
Leukemia & Lymphoma|January 24, 2004
Cellular pharmacology of P-ethoxy antisense oligonucleotides targeted to Bcl-2 in a follicular lymphoma cell lineYolanda Gutiérrez-Puente, Ana M Tari, Richard J Ford, et al.
Molecular Cancer Therapeutics|November 4, 2010
Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹⁰ p27 phosphorylation in epidermal growth factor receptor-expressing breast cancerDongwei Zhang, Ana M Tari, Ugur Akar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastomaHiroshi Aoki, Tomohisa Yokoyama, Keishi Fujiwara, et al.
The Lancet. Oncology|June 2, 2009
Imaging bone metastases in breast cancer: techniques and recommendations for diagnosisColleen M Costelloe, Eric M Rohren, John E Madewell, et al.
Cancer Research|November 17, 2007
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinomaJyotsnabaran Halder, Yvonne G Lin, William M Merritt, et al.
Pageof 4